• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

57.33 +0.83 (+1.47%)
Official Closing Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,600,646
Open 56.83
Bid (Size) 57.39 (100)
Ask (Size) 57.60 (100)
Prev. Close 56.50
Today's Range 56.52 - 57.79
52wk Range 49.26 - 66.28
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
June 11, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Decent Value Play with Strong Fundamentals ↗
June 10, 2026
Via Chartmill

Performance

YTD
-3.6%
-3.6%
1 Month
+8.4%
+8.4%
3 Month
+3.1%
+3.1%
6 Month
-4.7%
-4.7%
1 Year
+4.8%
+4.8%

More News

Read More
News headline image
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗
May 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
May 21, 2026
Via StockStory
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Opportunity with Strong Fundamentals and Accelerating Growth ↗
May 19, 2026
Via Chartmill
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 Earnings Miss Masked by Raised 2026 Guidance ↗
May 04, 2026
Via Chartmill
Topics Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a Compelling Value Stock ↗
April 17, 2026
Via Chartmill
News headline image
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky
May 21, 2026
Via StockStory
News headline image
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down
May 14, 2026
Via StockStory
Topics Credit Cards
News headline image
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 11, 2026
Via StockStory
Topics Earnings
News headline image
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook
May 05, 2026
Via StockStory
News headline image
BioMarin (BMRN) Q1 2026 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
News headline image
BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates
May 04, 2026
Via StockStory
News headline image
BioMarin (BMRN) Q4 2025 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
News headline image
BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect
May 02, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
April 13, 2026
Via MarketMinute
Topics Economy
News headline image
2 Profitable Stocks with Promising Prospects and 1 Facing Challenges
April 08, 2026
Via StockStory
News headline image
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
April 02, 2026
Via StockStory
Topics Government Stocks World Trade
News headline image
Ultragenyx Vaults Toward Commercialization as FDA Accepts Landmark Gene Therapy BLA
April 02, 2026
Via MarketMinute
Topics Intellectual Property Lawsuit
News headline image
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky
March 26, 2026
Via StockStory
News headline image
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗
March 20, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗
March 20, 2026
Via The Motley Fool
News headline image
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
March 19, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
March 16, 2026
Via The Motley Fool
News headline image
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗
March 16, 2026
Via The Motley Fool

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 57.33
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 06/24/26 04:15 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.51B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap